BAY-8400 is an orally active, potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (IC50=81 nM). BAY-8400 can be used for the research of cancer.

Product information

Molecular Weight: 395.41

Formula: C21H19F2N5O

Chemical Name: 8-(5-(difluoromethyl)pyridin-3-yl)-1-(oxepan-4-yl)-[1, 2, 4]triazolo[4, 3-a]quinoxaline

Smiles: FC(F)C1C=NC=C(C=1)C1=CC2=C(C=C1)N=CC1=NN=C(C3CCCOCC3)N12

InChiKey: AMSAFRUVFIAWDP-UHFFFAOYSA-N

InChi: InChI=1S/C21H19F2N5O/c22-20(23)16-8-15(10-24-11-16)14-3-4-17-18(9-14)28-19(12-25-17)26-27-21(28)13-2-1-6-29-7-5-13/h3-4,8-13,20H,1-2,5-7H2

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 ^oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 ^oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined

HS Tariff Code: 382200

How to use

In Vivo:

BAY-8400 (150 mg/kg; p.o.) increases the antitumor efficacy. BAY-8400 shows useful aqueous solubility and oral bioavailability across species.

Products are for research use only. Not for human use.